Mangoceuticals (MGRX) Shares Outstanding (2022 - 2026)

Mangoceuticals has disclosed Shares Outstanding (Entity) across 5 years of filings, most recently posting $18.0 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 69.27% year-over-year to $18.0 million; the TTM figure through Jun 2026 stood at $18.0 million (up 69.27% YoY), while the FY2025 annual figure was $10.1 million, up 408.93% from the prior year.
• Shares Outstanding (Entity) came in at $18.0 million for Q2 2026 at Mangoceuticals, up from $17.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $18.0 million in Q2 2026 to a low of $719908.0 in Q4 2022.
• Average Shares Outstanding (Entity) over 5 years is $5.6 million, with a median of $2.0 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) jumped 49.22% in 2023 and surged 447.99% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $719908.0 in 2022, then soared by 49.22% to $1.1 million in 2023, then jumped by 84.22% to $2.0 million in 2024, then surged by 408.93% to $10.1 million in 2025, then surged by 78.89% to $18.0 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $18.0 million in Q2 2026, $17.0 million in Q1 2026, and $10.1 million in Q4 2025.